TISSUE REGENERATION TECHNOLOGIES Announces That Its First Coronavirus Clinical Trial Has Been Initiated Utilizing Unfocused Shockwave Therapy (SoftWaves®)

ATLANTA, April 13, 2020 /PRNewswire/ -- Tissue Regeneration Technologies (TRT) announced today an important addition to our patent family to potentially aid in the fight against the Coronavirus. This patent applies the known mechanisms of action of unfocused shockwaves against this deadly...

from PR Newswire: https://ift.tt/2yaO755